In the life cycle of the yeast Saccharomyces cerevisiae, sexual conjugation between haploid cells of opposite mating types requires the function of hormone-like mating factors to coordinate the complex series of physiological processes involved in the mating reaction (5, 11) . Cells of the two alternative mating types, a and a, secrete into the culture medium one or more specific hormones that act on cells of the opposite mating type (6, 17) . Thus, an activity termed a factor has been isolated from culture filtrates of a cells that causes transient arrest of deoxyribonucleic acid synthesis and cell division in a cells (5, 6, 16) , whereas a corresponding a factor acting specifically on a cells has been detected in culture media of cells of mating type a (9, 17) .
Recently, the structure of a factor has been determined. It has been shown that, in culture filtrates of a cells, hormonal activity is associated with a group of closely related oligopeptides, which apparently originate from chemical and/or enzymatic alteration of a highly active tridecapeptide of the structure Trp-HisTrp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-MetTyr (14, 15) .
To obtain more information on the molecular mechanism of action of a factor, we have started to synthesize the hormone and several structural analogs possessing part of the amino acid sequence of the active tridecapeptide. In this paper we describe the biological effects of the tetrapeptide Trp-Leu-Gln-Leu and the pentapeptide His-Trp-Leu-Gln-Leu, both representing part of the N-terminal sequence of a factor. Using recovery from a factor inhibition as a quantitative assay, we found that the synthetic peptides, which by themselves possess no hormonal activity, stimulate the inhibitory action of a factor on a cells. We propose that this effect may result either from saturation of nonspecific a-factor-binding sites at the surface of the a cells by the peptides or from their interference with a process that inactivates the native hormone. Both mechanisms would lead to an increase of the effective a factor concentration and, thus, to an enhancement of the hormone activity.
MATERIALS AND METHODS
Yeast strains and culture conditions. The following were used as prototrophic wild-type strains: X2180-1A (haploid mating type a), X2180-1B (haploid mating type a), and X2180 (diploid a/a). The origin of these putatively isogenic strains was described earlier (6) . The auxotrophic strains XT309-5D a trp5-9 (obtained from T. R. Manney), XS144-S19 a trp5-1 leul lys5 aro2 ade5 metl3 cys2 (obtained from the Yeast Genetic Stock Center, University of California, Berkeley), and XV320-18D inol-13 ino4-8 trp5-1 leul ade6 metl gal2 canl (kindly provided by V. L. MacKay) were used for testing utilization of synthetic peptides. Strain XC41-1A (a trp5-9 leul his2) was constructed in our laboratory. Wildtype cells were grown on minimal medium (MV) 28 STIMULATION OF YEAST MATING HORMONE ACTIVITY containing 0.6% yeast nitrogen base (Difco Laboratories, Detroit, Mich.) and 2% glucose. For growth of auxotrophic strains, MV medium was supplemented with standard amino acids and purine and pyrimidine bases, as described by Manney (10) , to give synthetic complete medium (SC). Omission media lacking either tryptophan or leucine are designated as -TRP and -LEU, respectively. In some experiments MV medium was supplemented (per milliliter) with either 10 mg of tryptone (Difco), 10 mg of peptone (Difco), 10 mg of peptonized milk (Difco), 10 mg of Phytone (Becton, Dickinson and Co.), or 1.5 mg of chymotryptic digest of bovine serum albumin. The latter was prepared by incubation of a 1% (wt/ vol) solution of purified, reduced bovine serum albumin (Behringwerke, A.G., Marburg/Lahn, W. Germany) in 0.2 M phosphate (pH 8.2) with 0.1 mg of a-chymotrypsin (Merck) per ml for 24 h at room temperature. The digest, which was free from undegraded bovine serum albumin, was desalted by gel filtration on a Sephadex G10 and lyophilized.
Liquid cultures were grown aerobically at 30°C on a reciprocal shaker at 120 cycles per min. Growth was monitored either by counting cell numbers or by measuring turbidity in a Klett photometer. For determination of mating factor activities, cultures were grown in either MV (wild-type strains) or SC medium (mutant strains) to the early exponential phase. The cultures were then divided into 10-ml parallel samples. One sample served as a control. To the other cultures, hormones and/or peptides were added. All cultures were adjusted to the same cell density (between 1 x 106 and 2 x 106 cells per ml) and further incubated with aeration at 30°C. Cell numbers were monitored in a model F! Coulter Counter as described previously (3) .
Preparation of a and a factors. Partially purified a factor was obtained from culture filtrates of a cells (strain X2180-1B) as described previously (7) . The preparations were used after chromatography on Sephadex LH20. Biological activity was determined by the agar diffusion assay described earlier, 1 U of activity being defined as the lowest concentration causing the characteristic morphological response of a cells exposed to a factor (6) . The preparations contained between 10,000 and 50,00 U/ml. a factor was obtained from the growth medium of strain X2180-1A grown aerobically on MV medium for 24 h. The cell-free culture filtrates were passed through Amicon HlDP1O hollow-fiber membrane cartridges. More than 90% of the a factor activity was retained by each membrane, which is permeable for compounds of less than 10,000 molecular weight. The 300-fold-concentrated culture filtrates were used without further purification. Control experiments showed that the concentrates specifically inhibited cells of a mating type but did not affect the growth rates of haploid a or diploid a/a cells.
Digestion of tetrapeptide by crude cell extracts. Crude cell extracts were prepared, as described earlier (1), by grinding wet cells with three times their weight of aluminum oxide powder (Alcoa 305, bacteriological grade) and extracting with 4 volumes of 0.1 M potassium phosphate buffer, pH 6.4. To determine proteolytic activity, 3 ,tmol of the tetrapeptide Trp-Leu-Gln-Leu was incubated at 30°C in 0.1 M potassium phosphate buffer (pH 6.4) with 0.73 mg of extract protein in a total volume of 2.0 ml. A second sample containing only crude extract was incubated in parallel as a control for autolytic liberation of amino acids. Samples (0.1 ml) were taken at intervals and added to 0.1 ml of hot acidic ethanol (0.01 N HCI in 96% ethanol, 60°C). The denatured protein was removed by centrifugation. Portions of the supernatant were dried in a desiccator, dissolved in 0.2 M sodium citrate buffer (pH 2.0), and analyzed in a Biotronik model LC600L automated amino acid analyzer, using a standard program.
Synthesis of oligopeptides. The oligopeptides Trp-Leu-Gln-Leu and His-Trp-Leu-Gln-Leu and the methyl ester of the peptide Pro-Gly-Gln-Pro were synthesized by stepwise condensation of protected Lamino acids. The details of the synthesis will be described elsewhere (D. St6tzler, manuscript in preparation). The purity of the free peptides was examined by thin-layer chromatography on silica gel plates and by amino acid analysis after hydrolysis of 10 to 20 nmol of peptide in 3 M mercaptoethanesulfonic acid as described previously (14). Under these conditions significant amounts of tryptophan are recovered, and glutamine is completely hydrolyzed to glutamic acid. The results of typical analyses are given in Table 1 .
RESULTS
Determination of mating hormone activities. When cells of mating type a growing exponentially in liquid medium are treated with a factor, further cell division stops after approximately one generation (3; E. Bucking-Throm, Ph.D. thesis, Ruhr-Universitat Bochum, Bochum, Germany, 1973). After a period of inhibition, the length of which depends on the initial concentration of a factor, the cells recover and start to divide again (Bucking-Throm, Ph.D. thesis; 4, 16). At a factor concentrations less than 5 U/ml, the cells resume growth at the same rate as the untreated controls, and the length of the inhibition period increases with the initial a factor concentration (BuckingThrom, Ph.D. thesis; 4). Figure 1A shows the transient inhibition of exponentially growing a cells by increasing amounts of a factor added at zero time. Under the conditions of the experiment, 0.5 U of a factor per ml (approximately 10-8 M) inhibited the cells for 1.5 h; the inhibition caused by 2 U was for 4.6 h. The same type of inhibition occurred when increasing amounts of an a factor preparation were added to exponentially growing a cells (Fig. 1B) . The absolute length of the inhibition period by a given hormone concentration is influenced by several parameters, such as cell density, culture conditions (e.g., temperature, aeration, and pH of the medium), and growth rate of the cells used. However, under strictly controlled growth con- a Hydrolysis was performed in 3 M mercaptoethanesulfonic acid for 18 h at 105°C. Data in parentheses are molar ratios related to leucine (= 2.00) or glutamic acid (= 1.00).
b Values obtained by thin-layer chromatography on silica gel plates with (1) n-butanol-acetic acid-water (60:20:20, vol/ vol) and (2) n-butanol-pyridine-acetic acid-water (42:24:4:30, vol/vol).
c Methyl ester of tetrapeptide Pro-Gly-Gln-Pro. 1A ) by a factor. Symbols: 0, control without hormone; A, 0.5 U of a factor per ml ofculture; 0,1 U/ml; *, 2 U/ml. (B) Inhibition of a cells (strain X2180-1B) by a factor. Symbols: *, control without hormone; A, 0.0125 ml ofconcentrated a factor preparation per ml ofculture; 0, 0.025 ml/ ml; *, 0.05 ml/ml; A, 0.1 ml/ml. Hormone preparations were added at 0 h, and the cell densities were adjusted to approximately 106/ml. ditions with parallel fractions of the same culture, determination of the inhibition period provides a convenient and reproducible method to compare the inhibitory activities of different mating factor preparations and to assess the influence of various treatments on hormone action.
Biological activity of synthetic peptides. The oligopeptides His-Trp-Leu-Gln-Leu and Trp-Leu-Gln-Leu correspond to approximately one-third of the amino acid sequence of the native a peptides. To test whether these synthetic peptides possesed a factor activity, they were added at a final concentration of 8 x 10-5 M to a culture of a cells growing exponentially in MV medium. To parallel cultures, increasing amounts of the peptides (between 1.6 x 10-5 and 8 x 10-5 M) were added, together with 0.5 U of a factor per ml. Because of the low solubility of the pentapeptide, no higher concentrations could be used. Neither peptide affected the growth of the a cells (Fig. 2) , although an equimolar concentration of a factor would have inhibited cell division for more than 20 h (Bucking-Throm, Ph.D. thesis). However, both compounds caused significant extension of a factor arrest, the extent of this enhancement depending on the peptide concentration. Under the conditions of the experiment, the hormone alone inhibited the cells for 1.2 h, whereas in the presence of 8 x 10-5 M pentapeptide ( Fig.  2A ) the inhibition period was 3.9 h. Under comparable conditions such an effect would have required a three-to fourfold increase of the a factor concentration. The tetrapeptide exhibited a similar effect, increasing the inhibition period from 1.4 to 3.9 h at a concentration of 8 x 10-5 M (Fig. 2B) . Furthermore, in the presence of limited a factor concentrations that did not induce the characteristic morphology of LJ of a factor per ml; *, 0.5 U of a factor per ml plus 1.6 x 10-5 M peptide; A, 0.5 U of a factor per ml plus 3.2 x 10-5 M peptide; U, 0.5 U of a factor per ml plus 8 x 10-5 M peptide. Peptides and a factor were added at O h.
hormone-treated a cells (6), both peptides led to the typical morphological alterations. The influence of the synthetic peptides on a factor activity could also be demonstrated in other a strains. The data given in Table 2 show that in all strains tested the inhibition induced by a factor was extended by the tetrapeptide TrpLeu-Gln-Leu. As would have been expected, diploid cells (strain X2180), which are resistant even to high a factor concentrations (s50 U/ ml), did not respond to the hormone in the presence of 0.08 mM tetrapeptide. The observed variations in the inhibitory effect of the hormone and its enhancement by the peptide probably reflect differences in the genetic background of the strains.
To test whether the synthetic peptides specifically affected the interaction of the a mating hormone with a cells, their influence on the inhibitory effect of a factor on a cells was studied in a similar experiment. Inhibition of a cells (strain X2180-1B) by a factor was not enhanced by 8 x 10-5 M pentapeptide (Fig. 3) or by the same concentration of tetrapeptide (data not shown). In fact, in some experiments, a slight reduction of the inhibition period was observed (Fig. 3) .
The influence of nonspecific peptides on the action of a factor was investigated in the same type of experiment by adding random peptides from various sources, together with the hormone, to parallel cultures of growing a cells. The data presented in Table 3 clearly demonstrate that even high concentrations of random peptides do not increase the effect of a factor Similarly, a combination of free amino acids corresponding to the composition of the synthetic peptides also failed to increase the hormone effect (Table 3) . Furthermore, the methyl ester of the tetrapeptide Pro-Gly-Gln-Pro, which represents an amino acid sequence close to the C-terminus of a factor had no influence on the inhibition (Table 3 ). These observations indicate that the ability to stimulate a factor activity is related to the structural specificity of the peptides rather than being a general property of amino acids or oligopeptides. Utilization of synthetic peptides. The results described above are consistent with at least two hypotheses. The stimulatory action of the peptides could result from saturation of nonspecific a-factor-binding sites that are not involved in mediation of the hormone effect or from inhibition of an a-factor-inactivating sys- A concentration of free amino acids used in SC i3 medium for maximum growth stimulation.
-6 Both strains were able to grow on -TRP me-/ 5 dium in the presence of tetrapeptide (Fig. 4) , indicating that the N-terminal tryptophan resi- -4 due is readily utilized. In contrast, neither of the two leucine residues was available to sat-3 isfy the requirement of the double mutant XS144-S19 (Fig. 4B) . Similar results were obtained with the trp leu double mutants XV320-18D and XC41-1A, which also grow well in the tem. Both mechanisms would lead to an increased active hormone concentration and, thus, would enhance the inhibitory activity. Either of these effects could occur intra-or extracellularly. As a preliminary attempt to determine the site of action of the peptides, we studied their utilization by auxotrophic strains requiring tryptophan or leucine. As has been shown by Katzir-Katchalski and his co-workers (2, 13), yeast cells are able to utilize oligopeptides with varying degrees of efficiency, depending on the structural specificity of the compounds. The differences in utilization apparently reflect differences in the transport of peptides into the cells rather than variations in intracellular hydrolysis. Therefore, failure to satisfy the amino acid requirement of mutant strains would indicate that the synthetic peptides used in our study do not enter the cells efficiently and that their site of action is outside the cells. On the other hand, in the case of effective utilization, the interpretation would be less straightforward, since the effect could be due to an efficient uptake of the intact peptide as well as to extensive extracellular hydrolysis. Figure 4 shows the growth response of the auxotrophic strains XT309-5D and XS144-S19 to the tetrapeptide Trp-Leu-Gln-Leu. The cells were grown in -TRP or -LEU medium supplemented with 0.25 mM Trp-Leu-Gln-Leu peptides. This concentration is equivalent to the cruae extract oI strain AI144-619 tr1g. D).
DISCUSSION
That low concentrations of a factor cause transient arrest of exponentially growing a cells (Bucking-Throm, Ph.D. thesis; 3, 4) can be exploited to test the influence of various conditions on the activity of the hormone. Since the extent of the inhibition period is related to the hormone concentration (Fig. 1A) , determination of the time of arrest may be used to quantitatively compare different a factor prepara- c Methyl ester of tetrapeptide Pro-Gly-Gln-Pro (0.08 mM). tions. Unfortunately, standardization of the procedure in absolute terms is difficult because the a cell response may be influenced by a variety of parameters, such as cell numbers, growth characteristics ofthe strains used, aeration, or changes in the growth medium composition. The effect of these factors can be minimized, however, by using parallel fractions of the same culture growing under identical conditions. With these precautions, the inhibition periods induced by identical concentrations of a factor are reproducible, and, thus, a comparison of the hormone activity in different test cultures of the same set is possible.
The stimulatory influence of the synthetic oligopeptides Trp-Leu-Gln-Leu and His-TrpLeu-Gln-Leu on the action of a factor was rather unexpected. Since the structure of these peptides represents part of the N-terminal sequence of the a factor peptides, a competitive effect would have been anticipated. However, both peptides caused a drastic increase in the a factor-induced inhibition of a cells, the extent of which depended on the peptide concentration used. The peptides appear to enhance specifically the action of a factor on a cells since the inhibitory effect of a factor preparations on a cells was not influenced (Fig. 3) . Moreover, neither the equimolar mixture of the component amino acids nor random peptides obtained by limited digestion of various proteins stimulated a factor activity in this system (Table 3) . Most significantly, another tetrapeptide representing the amino acid sequence close to the Cterminal end of a factor was also ineffective (Table 3) . These findings strongly suggest that the effect of the synthetic oligopeptides is related to their structural specificity.
That the tetrapeptide Trp-Leu-Gln-Leu provides an adequate source of tryptophan for auxotrophic strains indicates that the cells are able to degrade the peptide efficiently either intraor extracellularly. Of these two mechanisms, intracellular degradation appears to be less likely, unless additional, more complicated assumptions are made, since neither of the two VOL. 132, 1977 leucine residues is available to satisfy the amino acid requirement of leucine auxotrophs. Apparently, this discrepancy cannot be explained by differences in the uptake characteristics of the strains, since the discrimination between tryptophan and leucine is found even with double auxotrophic mutants such as XS144-S19 (Fig. 4B) . This strain fails to grow on -LEU medium in the presence of tetrapeptide, although it contains peptidases that rapidly release all four amino acids (Fig. 5) . These results are consistent with the proposal that the peptide is not transported into the cells. Instead, it appears that it is partially degraded by an extracellular aminopeptidase activity, which liberates the N-terminal tryptophan but not the subsequent leucine residue. Conceivably, the partial hydrolysis could be catalyzed by the extracellular aminopeptidase activity that has been found to be associated with the cell wall or the periplasmic space ofSaccharomyces cells (12) . This interpretation of our results leads us to the assumption that the synthetic peptides interact with a site outside the cell membrane to stimulate the inhibitory effect of a factor.
The molecular mechanisms leading to the observed enhancement of a factor activity are not clear. There are at least two possible interpretations of our findings, which are not necessarily exclusive. The first rests on the assumption that a factor is degraded or inactivated on the surface of the responding cells. If the synthetic peptides did interfere with an inactivating system, they would cause an increase in the effective hormone concentration, thus extending the inhibition period. Another possible explanation would be that, in addition to its specific interaction with a cells, a factor is bound to the cell surface at sites that are not involved in mediation of the hormone effects. Competition of the synthetic peptides and a factor for such nonspecific sites would also lead to an increase of the effective hormone concentration and to an enhancement of the inhibitory effect.
There is evidence to support both of these two hypotheses. Hicks and Herskowitz (8) have described a diffusible factor produced by a cells that appears to inactivate a factor irreversibly. Moreover, it has been shown that a factor is gradually removed from the culture during the inhibition period and that the activity can no longer be demonstrated in the medium at the time growth is resumed (Bucking-Throm, Ph.D. thesis; 4). To date, attempts to recover a factor activity from a cells that have resumed growth have failed, suggesting that the hormone is converted into an inactive form or degraded. On the other hand, the native a-factor peptides have been shown to be very hydrophobic compounds that readily bind to a variety of polysaccharides such as dextrans or cellulose. When labeled with [3H]histidine, a factor was found to bind to a cells, but also to a cells and to diploids (G. Scherer and W. Duntze, unpublished data). In fact, because of low specific radioactivity of the hormone (0.2 mCi/mmol) that was available, it was not possible to detect a specific interaction with the sensitive a cells in these experiments. Nonspecific binding of a factor to surface structures of a cells is, therefore, a likely event that would decrease the effective hormone concentration. Competition of the synthetic peptides for the binding sites may suffice to explain their stimulatory effect(s). At present it is not possible to decide which one of the proposed explanations for the action of the peptides is correct. Conceivably, both mechanisms, interference with a factor inactivation as well as the reduction of nonspecific binding, could be involved in the stimulatory effect on a factor activity.
